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Abstract: Objective: Soluble guanylate cyclase (sGC), a heterodimer composed of  and  subunits, synthesizes cGMP in 
response to nitric oxide (NO). NO modulates vascular tone and structure but the relative contributions of cGMP-
dependent versus cGMP-independent mechanisms remain uncertain. We studied the response to vascular injury in male 
(M) and female (F) mice with targeted deletion of exon 6 of the sGC1 subunit (sGC1
-/-), resulting in a non-functional 
heterodimer. 
Methods: We measured aortic cGMP levels and mRNA transcripts encoding sGC 1,  2, and 1 subunits in wild   
type (WT) and sGCa1
-/- mice. To study the response to vascular injury, BrdU-incorporation and neointima formation 
(maximum intima to media (I/M) ratio) were determined 5 and 28 days after carotid artery ligation, respectively. 
Results: Aortic cGMP levels were 4-fold higher in F than in M mice in both genotypes, and, within each gender, 4-fold 
higher in WT than in sGCa1
-/-. In contrast, sGC1, sGC2, and sGC1 mRNA expression did not differ between groups. 
3H-thymidine incorporation in cultured sGCa1
-/- smooth muscle cells (SMC) was 27%±12% lower than in WT SMC and 
BrdU-incorporation in carotid arteries 5 days after ligation was significantly less in sGCa1
-/- M than in WT M. Neointima 
area and I/M 28 days after ligation were 65% and 62% lower in sGCa1
-/- M than in WT M mice (p<0,05 for both) but 
were not different in F mice. 
Conclusion: Functional deletion of sGCa1 resulted in reduced cGMP levels in male sGCa1
-/- mice and a gender-specific 
effect on the adaptive response to vascular injury. 
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INTRODUCTION 
  Nitric oxide (NO) plays an important role in maintaining 
normal vascular tone and modulates the function of vascular 
cells participating in the response to arterial injury. A better 
understanding of the molecular mechanisms regulating the 
response to vascular injury is fundamental to develop more 
effective therapies for atherosclerosis and restenosis follow-
ing percutaneous vascular interventions. In the vessel wall, 
NO is produced by endothelial nitric oxide synthase (NOS3). 
The main intracellular receptor of NO is soluble guanylate 
cyclase (sGC), a heterodimer composed of  and  subunits 
that catalyzes the conversion of GTP to cGMP in response to 
NO. A rise in cGMP can activate cGMP-dependent protein 
kinase 1 (cGKI) and result in vascular smooth muscle cell 
(SMC) relaxation. Recently, Mergia et al. reported that the 
targeted deletion of exon 4 of the sGC1 subunit results in a 
greater than 90% reduction in aortic NO-stimulated sGC 
activity [1]. 
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  NO/cGMP signal transduction, one of the critical path-
ways modulating vascular function, is reduced in athero- 
sclerosis [2] and after balloon injury [3]. Reduced NO 
bioavailability in the injured vessel wall is thought to con-
tribute to the progression of vascular lesions and has spurred 
interest in various interventions aimed at augmenting local 
NO/cGMP signal transduction. Among these, adenovirus-
mediated overexpression of NOS3 [4] or both sGC subunits 
with administration of molsidomine, a NO-donor [5], inhib-
its SMC proliferation in vitro and neointima formation in 
vivo in rats, suggesting a vasoprotective effect of NO/cGMP 
signaling. In line with these observations, ApoE
-/- NOS3
-/- 
mice have a larger neointima after femoral cuff placement 
[6] and carotid artery ligation [7] and show increased plaque 
development in an ApoE
-/- background [8, 9] as compared to 
WT mice. However, transgenic mice overexpressing NOS3 
in the vascular endothelium also show accelerated athero-
sclerosis [10], whereas mice with a SMC-specific deletion of 
cGKI (SMC-cGKI
-/-) develop less atherosclerosis [11]. 
These observations suggest that NO-mediated signal trans-
duction can have variable effects on the response to vascular 
injury, which might be related to an altered balance between 
cGMP-dependent signaling and cGMP-independent mecha-
nisms including S-nitrosylation of proteins and the genera-
tion of reactive oxygen species [12]. Gender-Specific Role of sGC in Vascular Tone and Injury  The Open Cardiovascular Medicine Journal, 2009, Volume 3    99 
  The role of cGMP in modulating the response to vascular 
injury has not been systematically studied. We, therefore, 
investigated the effect of reduced endogenous NO/cGMP 
signal transduction on the response to vascular injury in male 
(M) and female (F) mice with a targeted deletion of exon 6 
of sGC1 (sGC1
-/-). This deletion results in a non-
functional 11 heterodimer and is associated with systemic 
hypertension in male but not female sGC1
-/- mice [13]. We 
observed gender- and genotype-specific alterations in aortic 
cGMP levels, corresponding to the impaired neointimal   
response to carotid injury in male sGC1
-/- mice. Intact sGC 
gene function critically determines a gender-specific adap-
tive response to vascular injury. 
METHODS 
Experimental Animals 
 sGC1
-/- mice with a targeted deletion of exon 6 of the 
1 subunit gene were generated as described previously 
[13]. Experiments were performed in adult male and female 
sGC1
-/- (12 to 14 weeks old) and WT mice (10 to 16 weeks 
old) bread in a mixed genetic background (50% Swiss/50% 
129Sv). The experiments conformed with the Guide for the 
Care and Use of Laboratory Animals published by the US 
National Institutes of Health (NIH Publication No. 85-23, 
revised 1996) and were approved by the Institutional   
Committee on Animal Care and Welfare of the University of 
Leuven (Belgium). A schematic representation explaining 
the timeline of the experiments is shown in Fig. (1). 
Vascular cGMP Concentrations 
  The aorta was made bloodfree and immediately frozen  
in liquid nitrogen and kept at -80°C until vascular cGMP 
concentrations were determined using a non-radioactive   
enzyme immunoassay according to the manufacturer's in-
structions (Amersham Biosciences, Little Chalfont, United 
Kingdom). Protein concentrations were determined with the 
BCA Protein assay kit (Pierce, Rockford, IL) and results 
expressed as pmol cGMP/mg protein. 
sGC Subunit mRNA Expression 
  Assessment of mRNA transcript levels of murine sGC1 
(exon 5) sGC2, sGC1, and hypoxanthine-guanine phos-
phoribosyl-transferase (HPRT) was performed by real-time 
fluorescence detection using specific primer sets, recogniz-
ing the respective murine DNA sequences (see reference 
[14] for primer and probe sequences). Samples were run in 
triplicate together with a dilution series of a plasmid standard 
for each gene to allow comparison of the copy numbers   
of the different subunits. Results were expressed as copy 
numbers normalized to mHPRT. 
In Vitro SMC Proliferation and Migration 
  Experiments were performed in early passage aortic 
SMC (passage 4-6) isolated from WT and sGC1
-/- mice   
and cultured in DMEM + 10% fetal bovine serum.  DNA 
synthesis and migration in response to serum stimulation 
were assessed using 
3H-thymidine incorporation and Trans- 
well migration chambers (Corning, Corning, NY), respec-
tively. Results obtained with sGC1-/- cells were expressed 
relative to WT cells and represent the mean of 6 independent 
experiments. 
Carotid Artery Ligation 
  Animals were anesthetized with pentobarbital (65 mg/kg 
IP) and the common carotid artery was ligated close to the 
bifurcation as described previously [15]. Animals were 
euthanized 28 days after ligation to determine neointima 
formation. To evaluate vascular cell turnover in vivo, 5'-
bromo-deoxyuridine (BrdU, 50 mg/kg IP) was injected in a 
separate group of animals 12 hours and 1 hour before eutha-
nasia at 5 days when SMC turnover is maximal in the carotid 
artery ligation model [15]. Arteries were fixed in situ with 
4% formaldehyde, embedded in paraffin, and 5-μm sections 
were prepared from the bifurcation towards the aortic arch. 
The reference point was set at the first section containing an 
intact internal and external elastic lamina. 
Histological Analysis of Injured Carotid Arteries 
 To  quantitate neointima formation, sections were stained 
at 50 μm intervals with hematoxylin and eosin and analyzed 
by a blinded observer. Neointima area, media area, and in-
ternal elastic lamina (IEL) length were quantified using the 
KS300 morphometric analysis software (Zeiss, Oberkochen, 
Germany). The maximum intima to media (I/M) ratio (+50 
to +500 μm from the reference point in all animals) and the 
corresponding neointima area, media area, and IEL length 
were reported. BrdU-positive cells in the media were   
detected using a monoclonal rat anti-BrdU antibody (Oxford 
Biotechnology, Kidlington, UK) as described previously [14] 
and expressed relative to the total cell number. In addition, 
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cellular composition in neointimal and medial areas 28 days 
after ligation was investigated using antibodies directed 
against -smooth muscle actin (SMC actin) (Dako, Glostrup, 
Denmark) and CD45 (Becton Dickinson, Franklin Lakes, 
NJ), a common leucocyte antigen. Additional stainings with-
out primary antibody were included to control for non-
specific staining by secondary antibodies. Finally, the media 
area and IEL length of the contralateral carotid artery was 
quantitated to compare the response to increased flow in WT 
and sGC1-/- mice.  
Statistics 
  All values are expressed as mean±SD. A Student t-test 
was used to compare differences between 2 groups and   
one-way ANOVA to compare multiple groups. Post- 
hoc analysis was performed using the Student-Newman-
Keuls test or a Bonferroni correction (if variances were   
significantly different). 
  An expanded materials and methods section is available 
as online data supplement. 
RESULTS 
Effect of sGC1
-/-  and Gender on Vascular NO/cGMP 
Signaling 
  To investigate the effect of a truncated non-functional 
sGC11 heterodimer on sGC mRNA expression, quantita-
tive PCR (qPCR) was performed. Relative mRNA transcript 
levels of the sGC subunits were comparable between the 
four groups (Table 1). 
  To investigate gender and genotype-dependent effects on 
sGC gene function, unstimulated aortic cGMP levels were 
measured. cGMP levels were 4-fold higher in females than 
in males in both genotypes (p<0.05 each), and, within each 
gender, 4-fold higher in WT than in sGC1
-/- (p<0.05 each, 
Fig. 2). 
In Vitro SMC Proliferation and Migration 
  To evaluate the effect of sGC gene function on SMC 
proliferation, DNA turnover was quantified by measuring 
3H-thymidine incorporation in early passage SMC from 
sGC1
-/- and WT aortic explants. Proliferation was 
27%±12% lower in sGC1
-/- than in WT cells (n=6, p<0.05). 
In contrast, vascular cell migration was comparable in   
cells from both genotypes (97%±24%, n=6, p=ns). There 
was no difference between cells derived from male and   
female mice. 
 
 
 
 
 
 
 
 
 
 
 
Fig. (2). Vascular cGMP levels in WT (open bars) and sGC1
-/- 
(closed bars) male mice (M) and female mice (F). Aortic cGMP 
levels were 4-fold higher in F than in M mice in either genotype, 
and, within each gender, 4-fold higher in WT than in sGC1
-/- mice 
(* p<0.05 vs. all). 
Neointimal Response to Vascular Injury in sGC1
-/- 
Mice 
  To evaluate the role of sGC gene function in the adaptive 
response to vascular injury, the common carotid artery was 
surgically ligated in WT and sGC1
-/- mice. The maximum 
I/M ratio in both genotypes was observed at a distance rang-
ing from +50 to +500 μm proximal to the ligation, while 
almost no neointima was observed beyond +1000 μm. 
Maximum I/M ratio 28 days after ligation was lower in 
sGC1
-/- M than in WT M mice (p<0.05, Figs. 3A and 3B, 
respectively) but was not different in F mice (Fig. 4A). 
Neointima area was also lower in sGC1
-/- M compared to 
WT M or F mice of either genotype (p<0.05 vs. all). Media 
area and IEL length did not differ between groups (Table 2). 
The neointimal cells 4 weeks after ligation showed marked 
SMC actin immunoreactivity (Fig. 3C), while almost no 
CD45-positive inflammatory cells were observed in the 
neointima or the media (Fig. 3D). CD45 immunoreactivity 
was predominantly observed in the adventitia. 
 
Table 1.  Aortic mRNA Transcript Levels Normalized to HPRT  
   sGC1 sGC2 sGC1 
WT M (n=7)  11.8±7.0 1.5±0.3  25.4±7.3 
sGC1
-/- M (n=7)  8.4±2.2 1.6±0.5  16.4±5.2 
WT F (n=6)  13.1±3.9 1.7±0.5  18.3±2.7 
sGC1
-/- F (n=5)  11.5±9.5 1.8±0.9  19.8±10.0 Gender-Specific Role of sGC in Vascular Tone and Injury  The Open Cardiovascular Medicine Journal, 2009, Volume 3    101 
  We next investigated whether carotid artery ligation 
would differentially alter the response to increased flow in 
the contralateral carotid artery in both genotypes. There was 
no difference in media area or IEL length of the contralateral 
carotid artery in M or F mice (Table 2).  
BrdU-Incorporation 5 Days After Ligation 
  To investigate genotype-associated changes in SMC 
turnover following vascular injury, BrdU was injected 12 
hours and 1 hour before sacrifice in WT and sGC1
-/- mice. 
The proliferative index, expressed as % BrdU positive cells, 
was lower in sGC1
-/- M compared to WT M mice (p<0.05, 
Fig. 4B), which contributed to a reduced I/M ratio 28 days 
after ligation. There was no difference between sGC1
-/- F 
and WT F mice.  
DISCUSSION 
  NO/cGMP signal transduction plays an important role in 
maintaining normal vascular function and structure and 
modulates the response to arterial injury.  In the present 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. (3). The average maximum I/M ratio in WT male mice (panel A) was significantly higher than in sGC1
-/- male mice (panel B). The 
neointima (NI) was almost exclusively composed of SMC actin positive cells (panel C), while almost no CD45-positive cells (panel D) could 
be detected in the neointima or the media (M) between the internal and external elastic laminae (arrowheads, panel D). CD45 immunoreac-
tivity was predominantly observed in the adventitia (A). 
 
 
 
 
 
 
 
 
 
 
Fig. (4). Maximum I/M ratio 28 days after ligation was reduced in sGC1
-/- M compared to WT M mice and F mice of either genotype  
(* p<0.05 vs. all, panel A). Proliferation 5 days after ligation, expressed as % BrdU-positive cells/total number of cells, was also significantly 
lower in sGC1
-/- M than in WT M mice (* p<0.05 vs. WT M mice, panel B), while there was no difference in F mice. 102    The Open Cardiovascular Medicine Journal, 2009, Volume 3  Vermeersch et al. 
study, a targeted deletion in the sGC1 subunit resulting in  
a non-functional 11 heterodimer, was associated with a 
reduced response to vascular injury in male but not in female 
sGC1
-/- mice compared to WT mice. Male sGC1
-/- mice 
showed a significant reduction in DNA turnover in the   
remodeling arterial segment 5 days after carotid artery liga-
tion compared to male WT mice and a smaller neointimal 
area 28 days after ligation. No differences were observed 
between female sGC1
-/- and WT mice. These data suggest 
an important gender-specific effect of endogenous sGC gene 
function on the response to systemic vascular injury.  
  To investigate the effect of reduced sGC gene function 
on baseline NO/cGMP signal transduction in the vessel wall, 
we determined aortic cGMP concentrations in male and   
female WT and sGC1
-/- mice. Aortic cGMP levels were 
significantly lower in sGC1
-/- M than in sGC1
-/- F and WT 
F mice and accompanied by a reduced response to arterial 
injury. In contrast, higher cGMP levels in WT F mice com-
pared to WT M mice did not translate into a difference in  
the response to injury, suggesting a threshold cGMP level 
beyond which the vascular phenotype is no longer affected. 
Of note, these gender-specific differences were not observed 
in isolated aortic rings in a recent study by Nimmegeers   
et al. [16]. This is most likely due to the equilibration of  
aortic rings in an organ bath for 30 minutes before cGMP 
concentrations were measured in Nimmegeers et al. [16], 
while aortas in our study were immediately snap frozen. The 
gender-specific difference in cGMP levels we observed   
is consistent with previous observations of increased NO 
production in female rat aortas [17]. Moreover, the relative 
role of NO in acetylcholine-mediated vasorelaxation was 
more pronounced both in Wistar-Kyoto and spontaneously 
hypertensive female rats [18]. Deletion of sGC1 is also 
associated with a gender-specific effect on systemic blood 
pressure. Buys et al. recently reported that the deletion of 
sGCa1 results in systemic hypertension in male sGC1
-/- 
mice but not in female sGC1
-/- mice [13]. Taken together, 
these results point to a complex interplay between NO, sGC 
gene function and gender.  
  The reduced NO/cGMP signal transduction in sGC1
-/- 
mice did not result in altered mRNA transcript levels of the 
sGC subunits. Similarly, increased aortic cGMP levels in 
transgenic mice overexpressing NOS3 in the vascular endo-
thelium did not affect sGC1 protein expression [19, 20]. 
These observations demonstrate that the expression of sGC 
subunits in the aorta is not modulated via a NO or cGMP-
mediated feedback mechanism. In contrast, previous in vitro 
studies reported reduced sGC1 mRNA stability and protein 
expression in cultured SMC following the administration of 
an NO-donor [21] or a sGC activator [22], underlining the 
difficulty of extrapolating in vitro observations in cultured 
SMC to in vivo NO/cGMP signaling in the vessel wall. 
  Vascular injury results in reduced NO/cGMP signal 
transduction in the vessel wall [5]. Strategies aimed at   
increasing NOS3 expression [4] or reducing NOS uncou-
pling by administration of L-arginine have successfully re-
duced neointima formation in rats [23]. The role of endoge-
nous NO-mediated signaling in the adaptive response to in-
jury and the control of vascular SMC proliferation on the 
other hand remains unclear. The analysis of transgenic mice 
has shown that NO can both promote and inhibit vascular  
remodeling [12]. The opposing effects of NO most likely 
depend on the spatiotemporal profile of NO-production   
(including cellular source and quantity) and are probably 
mediated by different cGMP-dependent and cGMP-
independent mechanism [24]. 
  Wolfsgruber and colleagues showed that activation of 
cGKI in vitro promotes vascular SMC growth and that cGKI 
is critically involved in the ingrowth of SMC in vascular 
lesions during atherogenesis in an ApoE
-/- background [11]. 
Doubly deficient ApoE
-/- SMC-cGKI
-/-  had significantly 
smaller vascular lesions than ApoE
-/- mice. These results 
suggest that endogenous NO/cGMP/cGKI signaling stimu-
lates rather than inhibits vascular SMC proliferation and that 
the anti-proliferative effects are mediated by cGMP-
independent effects or cGMP-dependent cGKI-independent 
effects [12]. Stimulation of vascular SMC proliferation is 
potentially beneficial in atherosclerosis as SMC ingrowth 
could increase plaque stability and reduce the risk of an 
atherothrombotic event following plaque rupture. In our 
study, we observed a reduced response to vascular injury in 
sGC1
-/- M mice compared to WT M mice. Male NOS3
-/- 
Table 2.  Response to Vascular Injury in WT and sGC1
-/- Mice 
  WT M  sGC1
-/- M  WT F  sGC1
-/- F 
  Animals  n=6 n=7 n=6 n=7 
  IEL length (μm)  895±174 806±153 845±165 987±175 
   RCA  Neointima area (μm
2)  42,900±10,300 16,500±9,900* 36,600±21,900 43,400±21,600 
  Media area (μm
2)  35,400±8,700 35,300±7,400 28,100±8,900 34,700±3,700 
  I/M ratio  1.25±0.31 0.44±0.26* 1.31±0.72 1.21±0.60 
  % Stenosis  72%±19% 45%±31%* 68%±32% 61%±32% 
   LCA  IEL length (μm)  1,056±170 984±126 1,066±110 998±117 
  Media area (μm
2)  28,700±6,400 27,800±3,400 22,500±5,900 21,700±2,900 
RCA: injured right carotid artery; LCA: uninjured left carotid artery; IEL: internal elastic lamina; * p <0.05 vs. all Gender-Specific Role of sGC in Vascular Tone and Injury  The Open Cardiovascular Medicine Journal, 2009, Volume 3    103 
mice, in contrast, show increased neointima formation after 
carotid artery ligation [7]. The systemic hypertension in male 
sGC1
-/- M mice may have impacted on the response to   
vascular injury. Hypertensive Male NOS3
-/- mice do,   
however, show an increased response to vascular injury, 
while neointima formation is reduced in male sGC1
-/-  
mice. Taken together, these results support the view that 
endogenous NO/cGMP/cGKI signaling stimulates rather 
than inhibits vascular SMC proliferation and indicates that 
the antiproliferative effect of NO is most likely mediated via 
cGMP-independent pathways such as direct S-nitrosation of 
proteins or the formation of peroxynitrite [25]. 
  Studies in transgenic mice have also demonstrated that 
gender and pregnancy can affect the response to mechanical 
vascular injury. Male gender enhances the neointima forma-
tion in NOS3
-/- mice after femoral cuff placement, while 
pregnancy almost completely abolished the intimal response 
to vascular injury [6]. After femoral cuff placement, the 
neointima is almost exclusively composed of SMC as is the 
case after carotid artery ligation (Fig. 3C) [26]. Our results 
indicate that sGC could play a role in mediating gender-
specific effects on the response to vascular injury. Further 
research is, however, warranted to better characterize the 
underlying molecular mechanisms. It remains to be deter-
mined whether the gender-specific effect of the functional 
deletion of the sGC1 subunit on the response to vascular 
injury is testosterone-dependent as shown for systemic blood 
pressure [13]. Orchidectomy and treatment with an androgen 
receptor antagonist prevented hypertension in male sGC1
-/- 
mice, while ovariectomy did not influence systemic blood 
pressure in female mice. Moreover, chronic testosterone 
treatment increased blood pressure in ovariectomized 
sGC1
-/- mice, confirming that the effect of sGC on systemic 
blood pressure was testosterone-dependent.  
  The carotid artery ligation model used in this study   
has different characteristics than traditional injury models   
including wire injury. A study in ApoE
-/- mice after bone 
marrow transplant with GFP and LacZ-positive bone marrow 
cells showed that there was little contribution of bone-
marrow derived cells in the carotid artery ligation model 
compared to wire injury [26]. This model is therefore not 
fully representative of endovascular injury in patients. Our 
study on the other hand allows a relatively specific assess-
ment of the effects of reduced NO/cGMP signal transduction 
on vascular SMC function after vascular injury without   
endothelial denudation with only limited interference from 
of other cell types invading from the circulation (Figs. 3C 
and  2D). Studying the effect on SMC proliferation is of   
particular interest for the prevention of in-stent stenosis. 
While stenting prevents elastic recoil and in-stent restenosis, 
it is associated with increased SMC proliferation and   
migration [27]. Further research will be needed to improve 
our knowledge of NO-mediated cGMP-dependent and 
cGMP-independent mechanisms in the response to vascular 
injury to determine whether pharmacologic modulation of 
NO/cGMP signal transduction could be used to limit 
restenosis following PCI and to favor optimal healing of 
stented segments. 
  In summary, functional deletion of the sGC1 subunit 
gene resulted in an impaired response to carotid artery   
ligation in male sGC1
-/- mice but not in female sGC1
-/- 
mice compared to WT mice. The targeted deletion of sGC1 
elicits an important gender-specific effect on the response to 
vascular injury and may impact on future innovative thera-
pies for arterial injury. 
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ABBREVIATIONS 
ApoE =  Apolipoprotein  E 
BCA =  Bicinchoninic  acid 
BrdU =  5'-bromo-deoxyuridine 
cGK  =  cGMP-dependent protein kinase 
cGMP =  Cyclic  guanosine  monophosphate 
DMEM  =  Dulbecco's modified eagle medium 
GTP =  Guanosine  triphosphate 
HPRT =  Hypoxanthine-guanine  phosphoribosyltrans-
ferase 
IEL  =  Internal elastic lamina 
I/M ratio  =  Intima-to-media ratio 
IP =  Intraperitoneal  administration 
mRNA  =  Messenger ribonucleic acid 
NI =  Neointima 
NO =  Nitric  oxide 
NOS  =  Nitric oxide synthase 
qPCR =  Quantitative  polymerase  chain  reaction 
sGC  =  Soluble guanylate cyclase 
SMC =  Smooth  muscle  cell 
WT =  Wild  type 
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